SWA
GILD icon

SFMG Wealth Advisors’s Gilead Sciences GILD Stock Holding History

SFMG Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
1,875
+374
+25% +$49.3K 0.01% 285
2026
Q1 		$209K Buy
+1,501
New +$210K 0.01% 289
2023
Q3 		– Sell
-3,145
Closed -$242K – 266
2023
Q2 		$242K Sell
3,145
-37
-1% -$2.95K 0.02% 200
2023
Q1 		$264K Buy
3,182
+32
+1% +$2.65K 0.03% 197
2022
Q4 		$270K Buy
+3,150
New +$249K 0.03% 190
2022
Q3 		– Sell
-7,191
Closed -$444K – 262
2022
Q2 		$444K Buy
7,191
+578
+9% +$35.8K 0.05% 137
2022
Q1 		$393K Sell
6,613
-674
-9% -$43.1K 0.04% 166
2021
Q4 		$529K Buy
+7,287
New +$502K 0.05% 147
2016
Q4 		– Sell
-18,949
Closed -$1.5M – 118
2016
Q3 		$1.5M Buy
18,949
+8,500
+81% +$690K 0.33% 37
2016
Q2 		$872K Sell
10,449
-75
-0.7% -$6.66K 0.19% 49
2016
Q1 		$967K Sell
10,524
-95
-0.9% -$8.57K 0.21% 48
2015
Q4 		$1.07M Buy
10,619
+522
+5% +$54.3K 0.24% 50
2015
Q3 		$991K Sell
10,097
-2,670
-21% -$297K 0.24% 52
2015
Q2 		$1.5M Sell
12,767
-15,486
-55% -$1.69M 0.33% 40
2015
Q1 		$2.77M Buy
28,253
+13,964
+98% +$1.42M 0.22% 43
2014
Q4 		$1.35M Buy
+14,289
New +$1.48M 0.3% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SFMG Wealth Advisors's GILD Position: Q2 2026 in Review

SFMG Wealth Advisors increased its Gilead Sciences (GILD) stake by 25% in Q2 2026, buying an estimated $49.3K and bringing the position to 1,875 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #285.

SFMG Wealth Advisors first reported a position in GILD in Q4 2014 and has held it in 16 quarters since. The position peaked at $2.77M in Q1 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SFMG Wealth Advisors held 1,875 shares of Gilead Sciences worth $237K as of Q2 2026.
  • SFMG Wealth Advisors bought 374 Gilead Sciences shares in Q2 2026, an estimated $49.3K.
  • Gilead Sciences made up 0.01% of SFMG Wealth Advisors's portfolio in Q2 2026, its #285 holding.
  • SFMG Wealth Advisors first reported a position in Gilead Sciences in Q4 2014 and has held it in 16 quarters since.
  • SFMG Wealth Advisors's Gilead Sciences position peaked at $2.77M in Q1 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.